Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.
Syros Pharmaceuticals Inc SYRS revealed on Tuesday that the SELECT-MDS-1 Phase 3 trial of tamibarotene did not meet its primary endpoint of complete response rate. The trial assessed tamibarotene in ...
SAN ANTONIO – Thanks to efforts from doctors, researchers, health care providers and nonprofits such as Blood Cancer United, certain types of blood cancers are no longer the terminal diagnoses that ...
The AbbVie-Roche cancer drug venetoclax failed to meet its primary endpoint in a phase 3 trial to treat newly diagnosed higher-risk myelodysplastic syndrome, a form of blood cancer known as MDS, ...
Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...
On Monday, Good Morning America anchor Robin Roberts announced to viewers that she has been diagnosed with myelodysplastic syndrome, a blood and bone marrow disease once known as preleukemia. Roberts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback